- Home
- Vivo Ventures Vii, Llc
Insider Trading History of Vivo Ventures Vii, Llc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Vivo Ventures Vii, Llc since 2015.
The trader's CIK number is 1565020.
At the time of the last reporting, Vivo Ventures Vii, Llc was the 10% Owner of Codexis, Inc.. (stock ticker symbol CDXS).
Also see all insider trading activities at Codexis, Inc..
Note that in the past
VIVO VENTURES VII, LLC also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Codexis, Inc. (CDXS) by Vivo Ventures Vii, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | CDXS | 0 | $0 | 1,060,000 | $6,121,500 | 0 | $0 |
Yearly summary of insider trading at Mei Pharma, Inc. (MEIP) by Vivo Ventures Vii, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | MEIP | 0 | $0 | 390,572 | $720,362 | 0 | $0 |
Insider trading activities at 2 companies by Vivo Ventures Vii, Llc:
1. Codexis, Inc. (CDXS)
2. Mei Pharma, Inc. (MEIP)
Table 1. Insider trading of Codexis, Inc. (CDXS) by Vivo Ventures Vii, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-09-14 | CDXS | Sale | 1,060,000 | 5.78 | 6,121,500 |
Table 2. Insider trading of Mei Pharma, Inc. (MEIP) by Vivo Ventures Vii, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-11-09 | MEIP | Sale | 157,352 | 1.75 | 275,366 |
| 2015-11-06 | MEIP | Sale | 7,560 | 1.85 | 13,986 |
| 2015-11-05 | MEIP | Sale | 225,660 | 1.91 | 431,010 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Vivo Ventures Vii, Llc
(10% Owner of Codexis, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.